Key Facts Surrounding This News Item
- GWPH had a POWR Rating of B (Buy) coming into today.
- GWPH was -5.15% below its 10-Day Moving Average coming into today.
- GWPH was -2.35% below its 20-Day Moving Average coming into today.
- GWPH was 2.84% above its 50-Day Moving Average coming into today.
- GWPH was 5.22% above its 100-Day Moving Average coming into today.
- GWPH was 4.54% above its 200-Day Moving Average coming into today.
- GWPH had returned +3.80% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.
More Info About GW Pharmaceuticals Plc (GWPH)
GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. It operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The company was founded in 1998 and is based in Cambridge, the United Kingdom. View our full GWPH ticker page with ratings, news, and more.
Try StockNews.com Premium Today!
Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!